← SynDRA

LEDIPASVIR

SynDRA canonical compound SYN0037285 — structure-anchored drug synonym record

All known targets

• HCV NS5A
• NS5A

Mechanisms of action (all sources)

• HCV inhibitor
• Modulator

Drug classes

• Anti-Infective Agents
• Antiviral Agents
• P-Glycoprotein Inhibitors
• Breast Cancer Resistance Protein Inhibitors
• Hepatitis C Virus NS5A Inhibitor

ATC classes

• DIRECT ACTING ANTIVIRALS

Cross-references

• PubChem CID: 67505836
• ChEMBL: CHEMBL2374220
• DrugBank: DB09027
• ChEBI: CHEBI:85089
• KEGG: D10442
• RxNorm: 1591922
• Wikipedia: Ledipasvir
• TTD: D06LUZ
• LINCS BRD: BRD-K05446112

Synonyms

• GS-5885
• Ledipasvir acetonate
• Ledipasvir component of harvoni
• GS 5885
• UNII-013TE6E4WV
• GS5885
• WHO 9796
• Ledipasvir (GS5885)
• 013TE6E4WV
• CHEBI:85089
• methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate
• Ledipasvir [USAN:INN]
• Ledipasvir (USAN)
• SCHEMBL2706494
• SCHEMBL15116943
• CHEMBL2374220
• EX-A411
• DTXSID90154829
• MolPort-039-138-665
• HARVONI COMPONENT LEDIPASVIR
• ledipasvirum
• RefChem:798885
• DTXCID8077320
• MFCD25976756
• C49H54F2N8O6
• LEDIPASVIR ACETONATE [JAN]
• Ledipasvir [USAN]
• Ledipasvir?
• LedipasvirGS-5885
• LEDIPASVIR [MI]
• LEDIPASVIR [INN]
• Ledipasvir (USAN/INN)
• LEDIPASVIR [VANDF]
• LEDIPASVIR [WHO-DD]
• orb1688038
• LEDIPASVIR [ORANGE BOOK]
• SCHEMBL29361878
• SCHEMBL31341365

Reported adverse events

• Bradycardia
• Angioedema
• Asthenia
• Cough
• Depression
• Dizziness
• Fatigue
• Headache
• Insomnia
• Irritability
• Myalgia
• Nausea